Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases.
about
Concomitant pathologies among a spectrum of parkinsonian disordersClinicopathological outcomes of prospectively followed normal elderly brain bank volunteers.Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.Rapidly progressive diffuse Lewy body disease.Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body DisordersAre there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes.Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP?Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia.Genetics of Vascular Dementia.Postmortem interval effect on RNA and gene expression in human brain tissueArizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Neuropathological investigation of dementia: a guide for neurologists.Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients.Submandibular gland biopsy for the diagnosis of Parkinson diseaseIn vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain.The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007What is It? Difficult to Pigeon Hole Tremor: a Clinical-Pathological Study of a Man with Jaw TremorThe unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampusNon-fluent progressive aphasia, depression, and OCD in a woman with progressive supranuclear palsy: neuroanatomical and neuropathological correlations.Comparative study of commercially available anti-alpha-synuclein antibodies.Hirano body-rich subtypes of Creutzfeldt-Jakob disease.
P2860
Q28236077-54CD3B43-1FA6-413A-9C4F-7C650014F604Q33456273-FC649BC5-2819-4DA5-AD70-7B0B13A3C2E3Q33666765-B4ADE4C9-F59E-4F77-BD83-4AFCE05F3592Q33870090-AF1643EE-2D49-4023-B39E-6001C7C5A742Q33874572-53DD244B-DDE3-4D4F-A4BE-A1CC6682B6F2Q34083307-5A93735E-AE2C-4A38-BA69-073230E4ACD2Q34604146-87A80588-C0C3-4C04-9505-2862C017A234Q35028155-257F0BDB-1731-4D2E-9150-1338576D5B1FQ35050945-2C6B215B-E502-4183-9E99-608490088E02Q35094704-B9A21948-3538-482D-9CBC-A6463D24543DQ35930785-E3DEAB95-8408-4C4B-9E53-BB19A833E0EEQ36121377-72133E5A-607F-4517-A6D9-E27295AB11B2Q36314480-C83222B2-AB0B-4085-8316-6AA07ED49C21Q36488586-7449CBAC-C92D-4CC6-A91B-F54F219FB8DCQ36607622-01C1838E-D99F-49A5-8101-86285C9BC5F5Q36691547-7808E847-8CFC-4589-953D-CB9AEB35D9DDQ36805238-8289E5AB-7851-41FC-8401-6330AE06946EQ37015784-5C052F46-836E-40EE-98CF-D48B2E3664EDQ37164517-93325C94-EDDF-4ECA-9BC3-2B95DE6B22F5Q46462809-71C3325C-EB79-4AB9-9E58-00D6917BDDBEQ48566458-BB990350-E393-48A2-B039-CDBCCFE167ADQ49093525-59D8112D-4698-4AFC-99A7-1A8E4A53514D
P2860
Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Required techniques and useful ...... of neurodegenerative diseases.
@ast
Required techniques and useful ...... of neurodegenerative diseases.
@en
type
label
Required techniques and useful ...... of neurodegenerative diseases.
@ast
Required techniques and useful ...... of neurodegenerative diseases.
@en
prefLabel
Required techniques and useful ...... of neurodegenerative diseases.
@ast
Required techniques and useful ...... of neurodegenerative diseases.
@en
P2860
P1476
Required techniques and useful ...... of neurodegenerative diseases.
@en
P2860
P2888
P356
10.1007/S00401-004-0950-Z
P577
2005-01-11T00:00:00Z